Fructose in diet enhances tumor growth: research
New research suggesting that dietary fructose can enhance tumor growth by increasing circulating blood lipids has reignited debate over how sugar, especially high-fructose sources, influences cancer risk and progression. Commenters contrast the likely harms of industrial sugars and excessive fructose with the generally lower concern around whole fruits, while also scrutinizing popular ideas like ketogenic diets and fasting as cancer therapies, noting that human evidence remains limited and mixed. The exchange highlights broader frustrations with weak nutritional guidance in oncology, commercial incentives that favor drugs over diet research, and the difficulty of drawing clear, actionable rules from current metabolic and epidemiological data.
Steve Jobs, fruitarianism, and pancreatic cancer
- Multiple comments use Jobs as a cautionary tale: he tried to manage a surgically treatable pancreatic tumor with an extreme fruit-based diet and delayed surgery for months.
- Some argue his fruitarianism might have contributed to cancer (e.g., possible micronutrient deficiencies); others say current science doesn’t support clear causal claims and emphasize that pancreatic cancer is generally lethal.
- Consensus: his delay of conventional treatment likely cost him years, but whether fruit “caused” or worsened his cancer is unclear.
Keto, fasting, and diet-based cancer strategies
- Debate over ketogenic diets: some claim “not much evidence” they outperform other exclusion diets; others insist strong evidence exists, citing ongoing trials and case reports.
- Fasting and ketosis are discussed as potentially enhancing anti-cancer defenses or sensitizing tumors, but there is also a mouse study where a ketogenic diet reduced primary tumor growth yet increased metastasis.
- Several commenters stress that diet alone cannot cure cancer; at best it may make the body more or less hospitable or interact with therapies.
Fructose, HFCS, and metabolic effects
- The study’s main point highlighted: tumors barely metabolize fructose directly; the liver converts dietary fructose into lipids that circulate and feed tumors.
- Fructose is linked in discussion to higher triglycerides, uric acid, non-alcoholic fatty liver disease, and possibly shared pathways with alcohol in the liver.
- Strong clarification that HFCS and table sugar are compositionally similar (~50% fructose), so swapping one for the other is largely a health “no-op”; the real issue is total added sugar and its ubiquity.
Whole fruit vs processed sugar
- Broad agreement that whole fruits are usually fine due to fiber and nutrient content; fruit juice, dried fruit, and large doses of industrial fructose are more concerning.
- Some worry modern cultivars are sweeter and less nutrient-dense; others challenge this as unproven FUD, though there are anecdotal and agricultural arguments.
- Comparisons note how hard it is to overeat whole fruit relative to sugary drinks.
Nutrition, medicine, and incentives
- Several note a striking lack of structured nutritional guidance in oncology care.
- Discussion links this to weak profit incentives for diet research versus drugs, high trial costs, and systemic time pressure on clinicians.
- Overall tone: diet clearly matters for metabolic health and risk, but its precise role in cancer progression and treatment remains contested and incomplete.